Cargando…
Glycemic Control: A Combination of Lifestyle Management and the Use of Drugs
Some 30% of contemporary cardiology patients have coexisting known diabetes, and another 40% have either undiagnosed diabetes or prediabetes. There is still no final conclusive evidence of cardiovascular benefit by good glycemic control in type 2 diabetes, although studies like the United Kingdom Pr...
Autores principales: | Standl, Eberhard, Erbach, Michael, Schnell, Oliver |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4107439/ https://www.ncbi.nlm.nih.gov/pubmed/25135285 http://dx.doi.org/10.1007/s40119-012-0007-7 |
Ejemplares similares
-
Defending the Con Side: Obesity Paradox Does Not Exist
por: Standl, Eberhard, et al.
Publicado: (2013) -
On the potential of acarbose to reduce cardiovascular disease
por: Standl, Eberhard, et al.
Publicado: (2014) -
Postprandial Hyperglycemia and Glycemic Variability: Should we care?
por: Standl, Eberhard, et al.
Publicado: (2011) -
Heart failure outcomes and Covid-19
por: Standl, Eberhard, et al.
Publicado: (2021) -
Current perspectives on cardiovascular outcome trials in diabetes
por: Schnell, Oliver, et al.
Publicado: (2016)